We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Rheumatology

Journal Scan / Research · December 14, 2021

Clinical Features of Systemic Sclerosis Patients With Anti-PM/ScI Antibodies

Rheumatology (Oxford, England)


Additional Info

Rheumatology (Oxford, England)
The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort
Rheumatology (Oxford) 2021 Nov 03;60(11)5028-5041, MG Lazzaroni, E Marasco, C Campochiaro, J DeVries-Bouwstra, MI Gonzalez-Perez, J Rojas-Serrano, E Hachulla, E Zanatta, S Barsotti, F Furini, K Triantafyllias, G Abignano, ME Truchetet, G De Luca, E De Langhe, R Hesselstrand, F Ingegnoli, E Bertoldo, V Smith, S Bellando-Randone, H Poormoghim, E Colombo, A Ceribelli, A Furloni, S Zingarelli, I Cavazzana, F Franceschini, F Del Galdo, CP Denton, L Cavagna, O Distler, Y Allanore, P Airò

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading